Release of tumor necrosis factor-α and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin
Background: The preventive effect of low-dose aspirin in cardiovascular disease is generally attributed to its antiplatelet action caused by differential inhibition of platelet cyclooxygenase-1. However, there is evidence that aspirin also affects release of inflammatory cytokines, including tumor n...
Main Authors: | Ilse Beckmann, Shlomo Ben-Efraim, Monica Vervoort, Henk C. S. Wallenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2001-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350120054554 |
Similar Items
-
Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood
by: Rütten, Simon, et al.
Published: (2016) -
Prostanoids in allergy
by: Tetsuya Honda, et al.
Published: (2015-01-01) -
The synthesis of novel prostanoids
by: Elder, J. S.
Published: (1982) -
Differentiation of prostanoid receptors
by: Dong, Yijie
Published: (1984) -
Prostanoids in health and disease
by: Emer M. Smyth, et al.
Published: (2009-01-01)